Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES J MARCZAK

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1720123805
CMS profile
11013347
Location
GLENDALE, AZ

General Payments · PY2021–2024

$3,965.55

  • Reported across 119 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,342.67

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,342.67 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $591.97 9
Abbott Laboratories $166.93 4
Amgen Inc. $155.00 5
GlaxoSmithKline, LLC. $125.00 1
Novo Nordisk AS $98.89 6
Teva Pharmaceuticals USA, Inc. $84.85 4
PFIZER INC. $73.94 4
BOSTON SCIENTIFIC CORPORATION $17.32 1
ABBVIE INC. $14.86 1
Exact Sciences Corporation $13.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,025.67 14
PY2022 $395.16 17
PY2023 $1,202.05 52
PY2024 $1,342.67 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $9.07 06/11/2024 Food and Beverage Undisputed 01/23/2026 1125217080 CMS
Abbott Laboratories $23.16 09/12/2024 Food and Beverage Undisputed 01/23/2026 1125217082 CMS
Abbott Laboratories $109.90 10/23/2024 Food and Beverage Undisputed 01/23/2026 1125217084 CMS
Abbott Laboratories $24.80 12/30/2024 Food and Beverage Undisputed 01/23/2026 1125217086 CMS
ABBVIE INC. $14.86 01/02/2024 Food and Beverage Undisputed 01/23/2026 1107589705 CMS
Amgen Inc. $7.96 05/23/2024 Food and Beverage Undisputed 01/23/2026 1115902848 CMS
Amgen Inc. $124.56 06/27/2024 Food and Beverage Undisputed 01/23/2026 1115902863 CMS
Amgen Inc. $7.39 07/11/2024 Food and Beverage Undisputed 01/23/2026 1115902853 CMS
Amgen Inc. $7.15 08/15/2024 Food and Beverage Undisputed 01/23/2026 1117619692 CMS
Amgen Inc. $7.94 11/25/2024 Food and Beverage Undisputed 01/23/2026 1117619694 CMS
AstraZeneca Pharmaceuticals LP $33.00 01/04/2024 Food and Beverage Undisputed 01/23/2026 1104610030 CMS
AstraZeneca Pharmaceuticals LP $125.93 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105844991 CMS
AstraZeneca Pharmaceuticals LP $124.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 1104618426 CMS
AstraZeneca Pharmaceuticals LP $13.65 03/22/2024 Food and Beverage Undisputed 01/23/2026 1104642451 CMS
AstraZeneca Pharmaceuticals LP $18.56 08/15/2024 Food and Beverage Undisputed 01/23/2026 1104741663 CMS
AstraZeneca Pharmaceuticals LP $124.56 08/21/2024 Food and Beverage Undisputed 01/23/2026 1104623114 CMS
AstraZeneca Pharmaceuticals LP $13.74 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105255154 CMS
AstraZeneca Pharmaceuticals LP $121.65 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104512218 CMS
AstraZeneca Pharmaceuticals LP $16.32 11/18/2024 Food and Beverage Undisputed 01/23/2026 1105774478 CMS
Boston Scientific Corporation $17.32 08/28/2024 Food and Beverage Undisputed 01/23/2026 1092676223 CMS
Exact Sciences Corporation $13.91 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114471908 CMS
GlaxoSmithKline, LLC. $125.00 05/15/2024 Food and Beverage Undisputed 01/23/2026 1116173421 CMS
Novo Nordisk Inc $15.39 02/05/2024 Food and Beverage Undisputed 01/23/2026 1100398706 CMS
Novo Nordisk Inc $14.55 02/22/2024 Food and Beverage Undisputed 01/23/2026 1100536407 CMS
Novo Nordisk Inc $18.47 03/15/2024 Food and Beverage Undisputed 01/23/2026 1100482143 CMS
Novo Nordisk Inc $15.64 06/21/2024 Food and Beverage Undisputed 01/23/2026 1100364793 CMS
Novo Nordisk Inc $17.59 08/01/2024 Food and Beverage Undisputed 01/23/2026 1100447801 CMS
Novo Nordisk Inc $17.25 10/24/2024 Food and Beverage Undisputed 01/23/2026 1100543430 CMS
PFIZER INC. $21.97 02/01/2024 Food and Beverage Undisputed 01/23/2026 1131167427 CMS
PFIZER INC. $15.76 03/21/2024 Food and Beverage Undisputed 01/23/2026 1131285932 CMS
PFIZER INC. $17.04 05/02/2024 Food and Beverage Undisputed 01/23/2026 1131330004 CMS
PFIZER INC. $19.17 06/27/2024 Food and Beverage Undisputed 01/23/2026 1131672947 CMS
Teva Pharmaceuticals USA, Inc. $23.98 07/02/2024 Food and Beverage Undisputed 01/23/2026 1151700863 CMS
Teva Pharmaceuticals USA, Inc. $33.06 09/19/2024 Food and Beverage Undisputed 01/23/2026 1151700883 CMS
Teva Pharmaceuticals USA, Inc. $13.54 10/14/2024 Food and Beverage Undisputed 01/23/2026 1151700889 CMS
Teva Pharmaceuticals USA, Inc. $14.27 12/11/2024 Food and Beverage Undisputed 01/23/2026 1151700899 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.